Piramal Pharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Piramal Pharma Limited generated cash of $10,045,400,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,223,600,000 last year. Net change in cash is therefore $1,659,600,000.
Cash Flow
| 2021 | 347.2M | -43.82B | 44.94B |
|---|---|---|---|
| 2023 | 4.83B | -13.38B | 8.17B |
| 2024 | 10.04B | -4.56B | -4.22B |
PPLPHARMA.NS Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2020 | |
|---|---|---|---|
Cash at beginning of period | 532.3M | 851.8M | 7.4M |
Operating activities | |||
Net income | 178.2M | -1.67B | 3.49B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 7.40B | 6.76B | 609.6M |
Stock-based compensation expense | 274.7M | 0 | 0 |
| Deferred income tax benefit | 274.7M | 0 | 0 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -3.91B | 892.6M | -4.75B |
Inventories | -5.31B | -1.72B | 953.6M |
Accounts payable | 4.04B | -2.64B | 4.75B |
Cash generated by operating activities | 10.04B | 4.83B | 347.2M |
Investing activities | |||
Purchases Of Investments | -16.90B | -12.23B | 0 |
Investments In Property Plant And Equipment | -7.12B | -9.64B | -581.1M |
Acquisitions Net | 0 | -936.6M | -37.75B |
Cash generated by investing activities | -4.56B | -13.38B | -43.82B |
Financing activities | |||
Common Stock Issued | 10.5B | 0 | 42.33B |
Payments for dividends | 0 | -670M | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | -9.71B | 11.98B | -3.83B |
Cash used in financing activities | -4.22B | 8.17B | 44.94B |
Net Change In Cash | 1.65B | -319.5M | 1.45B |
Cash at end of period | 2.19B | 532.3M | 1.46B |
| Data source | Data source | Data source |